GNCA

AcronymDefinition
GNCAGram-Negative Core Antigens
References in periodicals archive ?
It plans to list on the NASDAQ under the symbol GNCA. Genocea Biosciences initially filed confidentially on October 22, 2013.
(NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today reported its operating and financial results for the quarter ended June 30, 2019.
Genocea (GNCA), up 88% after announcing clinical results from its ongoing Phase 1/2a trial for GEN-009, the company's neoantigen vaccine candidate...
(NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock.
Genocea (GNCA) initiated with an Overweight at Cantor Fitzgerald.